The Multiple System Atrophy Coalition
Non-Profit & Charitable Organizations · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7918 Jones Branch Dr Ste 300, Mc Lean, V...Phone Number
(866) 737-4999Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About The Multiple System Atrophy Coalition
Mission MSA is dedicated to supporting individuals and families affected by Multiple System Atrophy (MSA), a rare neurodegenerative disorder. They provide resources, community support, and education to help navigate the challenges of living with MSA, while also advocating for research towards treatments and a cure. Their intended clients include patients, caregivers, and families impacted by MSA seeking guidance and a supportive network. Through various initiatives, they aim to improve the quality of life for those dealing with this condition.Explore more
The Multiple System Atrophy Coalition Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The Multiple System Atrophy Coalition your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on The Multiple System Atrophy Coalition recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at The Multiple System Atrophy Coalition
Funding: Get notified immidiatlly once The Multiple System Atrophy Coalition has new funding data
The Multiple System Atrophy Coalition, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if The Multiple System Atrophy Coalition is spiking on competitors!
Product Launch: Get notified when The Multiple System Atrophy Coalition launches new products
Website visits: Recent activity has been detected on your website
Check if The Multiple System Atrophy Coalition has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if The Multiple System Atrophy Coalition had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at The Multiple System Atrophy Coalition
Find 3 more new buyers
Compare Similar Companies to The Multiple System Atrophy Coalition
Compare insights from companies similar to The Multiple System Atrophy Coalition, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The Multiple System Atrophy Coalition is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
The Multiple System Atrophy Coalition is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about The Multiple System Atrophy Coalition.
The Multiple System Atrophy Coalition Tech Stack
A closer look at the technologies used by The Multiple System Atrophy Coalition
The Multiple System Atrophy Coalition News & Media
Exidavnemab phase 2a study expanded to include MSA patients
STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System Atrophy (MSA) patients for treatment with the alpha-synuclein antibody exidavnemab in the...BioArctic receives Orphan Drug Designation for exidavnemab the US
STOCKHOLM, March 17, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment of Multiple System Atrophy (MSA), providing...BioArctic receives Orphan Drug Designation for exidavnemab the US
STOCKHOLM, March 17, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment of Multiple System Atrophy (MSA), providing...The Multiple System Atrophy Coalition Surpasses $3.5 Million in Total...
The Multiple System Atrophy (MSA) Coalition, the leading nonprofit funder of global MSA research, announced that the organization has reached the milestone of investing more than $3.5 million in total... (PRWeb December 14, 2022) Read the full story at https://www.prweb.com/releases/the_multiple_system_atrophy_coalition_surpasses_3_5_million_in_total_msa_research_funding/prweb19076699.htm
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The Multiple System Atrophy Coalition
Sign Up For FreeTo access detailed company insights
Mission MSA is dedicated to supporting individuals and families affected by Multiple System Atrophy (MSA), a rare neurodegenerative disorder. They provide resources, community support, and education to help navigate the challenges of living with MSA, while also advocating for research towards treatments and a cure. Their intended clients include pa... Read More
